Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
2.310
-0.060 (-2.53%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Jaguar Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29.57 | 11.51 | 11.69 | 9.76 | 11.96 | 4.34 | |
Revenue Growth (YoY) | 155.96% | -1.52% | 19.75% | -18.36% | 175.80% | -53.81% |
Cost of Revenue | 4.42 | 3.77 | 1.96 | 2.04 | 2.02 | 2.33 |
Gross Profit | 25.15 | 7.74 | 9.73 | 7.72 | 9.94 | 2 |
Selling, General & Admin | 25.49 | 27.88 | 24.02 | 23.05 | 26.71 | 26 |
Research & Development | 25.16 | 24.97 | 16.54 | 18.6 | 17.65 | 15.08 |
Other Operating Expenses | - | 0.8 | - | 0.37 | - | 1.63 |
Total Operating Expenses | 50.66 | 53.65 | 40.57 | 42.02 | 44.35 | 42.71 |
Operating Income | -26.31 | -45.91 | -30.83 | -34.29 | -34.42 | -40.71 |
Interest Expense | - | - | - | -6.38 | -12.72 | -8.42 |
Other Non-Operating Income (Expense) | -8.37 | -8.09 | -8.42 | -1.23 | -1.26 | -3.47 |
Total Non-Operating Income (Expense) | -8.37 | -8.09 | -8.42 | -7.61 | -13.98 | -11.89 |
Pretax Income | -34.68 | -54 | -39.25 | -41.9 | -48.4 | -52.6 |
Net Income | -34.68 | -54 | -39.25 | -41.9 | -48.4 | -52.6 |
Minority Interest in Earnings | -0.56 | -0.56 | -0.76 | -0.6 | -0.94 | -0.01 |
Net Income Attributable to Preferred Dividends | -9.8 | -0.14 | - | - | - | - |
Net Income to Common | -50.13 | -53.58 | -38.49 | -41.3 | -47.45 | -52.6 |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 399.24% | 691.89% | 1809.96% | 1663.72% | 119.99% | 247.08% |
EPS (Basic) | -605.10 | -803.95 | -4574.15 | -93736.00 | -1899450.00 | -4631550.00 |
EPS (Diluted) | -605.10 | -803.95 | -4574.15 | -93736.00 | -1899450.00 | -4631550.00 |
Free Cash Flow | -7.54 | -23.73 | -29.4 | -33.26 | -33.18 | -34.38 |
Free Cash Flow Per Share | -40.80 | -356.05 | -3493.65 | -75483.40 | -1328230.00 | -3027170.00 |
Gross Margin | 85.06% | 67.21% | 83.27% | 79.13% | 83.11% | 46.18% |
Operating Margin | -88.96% | -398.82% | -263.76% | -351.31% | -287.85% | -939.05% |
Profit Margin | -117.28% | -469.09% | -335.79% | -429.27% | -404.78% | -1213.38% |
FCF Margin | -25.51% | -206.12% | -251.52% | -340.72% | -277.53% | -792.99% |
EBITDA | -24.4 | -44 | -28.93 | -32.28 | -32.43 | -38.99 |
EBITDA Margin | -82.51% | -382.20% | -247.51% | -330.68% | -271.28% | -899.40% |
EBIT | -26.31 | -45.91 | -30.83 | -34.29 | -34.42 | -40.71 |
EBIT Margin | -88.96% | -398.82% | -263.76% | -351.31% | -287.85% | -939.05% |